Weekly News Recap #Phispers | PharmaCompass.com

FDA approves Emergent’s smallpox vaccine for mpox; Lilly inks up to US$ 1 bn deal with Haya to target obesity

This week saw the US Food and Drug Administration (FDA) respond to the global monkeypox (mpox) public health emergency by expan...

Impressions : 726

Lilly, Pfizer move to sell drugs directly to consumers; blast at Indian drug factory kills 17

An Indian factory that makes drugs for export to the US and other Western nations saw an explosion, caused by a chemical solven...

Impressions : 1313

IRA price talks conclude, three meds dominate savings; Gilead’s Livdelzi from CymaBay buyout gets FDA okay

This week, the Biden-Harris Administration said it has concluded price negotiations for 10 drugs under the Inflation Reduction ...

Impressions : 525

FDA rejects first MDMA therapy to treat PTSD; Merck, Curon ink up to US$ 1.3 bn deal for next-gen bispecific antibody

The US Food and Drug Administration (FDA) has declined to approve an MDMA-assisted therapy from Lykos Therapeutics to treat pos...

Impressions : 1210

FDA approves first ever T-cell receptor gene therapy from Adaptimmune, Servier’s brain tumor pill

This week, Adaptimmune clinched gold when it secured the first-ever US Food and Drug Administration (FDA) approval for a T-cell...

Impressions : 716

Boehringer boosts immune-oncology pipeline with US$ 1.3 bn Nerio buy; Pfizer adds US$ 1 bn to 2024 outlook

This week, the world’s largest private pharma company, Boehringer Ingelheim, acquired Nerio Therapeutics for up to US$ 1....

Impressions : 609

Merck’s RSV jab shows efficacy in infants; Novo-Lilly weight loss rivalry intensifies as China okays tirzepatide

This was a week when the US President Joe Biden ended his reelection bid, after giving America the Inflation Reduction Act that...

Impressions : 829

US Senate passes bipartisan bill to cut pharma patent abuses; Ipsen inks another ADC deal

This week, a bill heralded as “critical” to help “end anti-competitive practices” was passed by the US ...

Impressions : 1098

Lilly to acquire IBD drug developer Morphic for US$ 3.2 bn; Pfizer’s R&D chief to step down

This week saw Eli Lilly strike yet another deal as it announced the acquisition of Morphic Holding for about US$ 3.2 billion, t...

Impressions : 868

Lilly’s Alzheimer’s drug gets FDA nod; GSK buys rights to mRNA vaccines from Curevac for US$ 1.56 bn

This week, the US Food and Drug Administration (FDA) finally approved Eli Lilly’s Alzheimer’s drug donanemab after ...

Impressions : 673

Novo invests US$ 4.1 bn to boost Wegovy, Ozempic supply; Verona’s COPD therapy bags FDA nod

This week saw a couple of developments in the lucrative US market for glucagon-like peptide-1 (GLP-1) drugs that treat diabetes...

Impressions : 831

Merck wins FDA nod for pneumococcal vaccine; Roche partners Ascidian to develop novel gene therapies

This week saw the US Food and Drug Administration (FDA) approve Merck’s next-generation pneumococcal vaccine for adults. ...

Impressions : 949

FDA panel backs Lilly’s Alzheimer’s drug; agency approves Ipsen’s med to treat rare liver disease

The US Food and Drug Administration’s (FDA) advisory committee has voted unanimously in favor of the benefits of Eli Lill...

Impressions : 706

Astra’s cancer drugs impress at ASCO; Moderna’s mRESVIA becomes first mRNA RSV vaccine approved by FDA

This week saw the American Society of Clinical Oncology (ASCO) annual meeting in Chicago where cancer researchers presented det...

Impressions : 756

Lilly to invest additional US$ 5.3 bn to boost obesity drug supply; FDA panel votes against Novo’s weekly insulin

This week’s Phispers comes packed with news of investments, acquisitions, deals and trials. Eli Lilly has more than doubl...

Impressions : 1185

Astra targets US$ 80 bn revenue by 2030, invests US$ 1.5 bn in ADC plant; Lilly’s weekly insulin scores late-stage wins

In this week’s news, AstraZeneca has laid out an ambitious plan to achieve US$ 80 billion in revenue by 2030. The drugmak...

Impressions : 532

France draws US$ 2.25 bn investment from Big Pharma; Sanofi strikes US$ 1.2 bn deal with Novavax

In this week’s news, France attracted investments from pharma majors such as Sanofi, Pfizer, AstraZeneca and GSK during t...

Impressions : 862

FDA to consider psychedelic-assisted drug for treating PTSD; Novartis buys Mariana Oncology for up to US$ 1.75 bn

Last year, the US Food and Drug Administration (FDA) had published a new draft guidance for researchers investigating the use o...

Impressions : 621

FTC disputes relevance of over 300 patent listings; Japan’s Ono to buy Deciphera for US$ 2.4 bn

The price of drugs is the highest in the US, and the White House has been working on bringing down drug prices for several year...

Impressions : 840

ImmunityBio bags maiden FDA nod for bladder cancer; Ipsen, Skyhawk partner to develop neurological therapies

This week’s Phispers comes packed with news about drug approvals by the US Food and Drug Administration (FDA). The agency...

Impressions : 657

US panel accuses China of subsidizing fentanyl production; Nigeria introduces 5-in-1 meningitis vaccine

This week’s news brings a mix of promising advancements and concerning issues. A majority of opioid overdose deaths...

Impressions : 1402

Vertex buys Alpine Immune Sciences for US$ 4.9 billion; Merck KGaA signs ADC deal with AI biotech Caris

This week’s Phispers comes packed with deals, approvals and trial wins. Vertex Pharmaceuticals has decided to bet big on ...

Impressions : 1245

Genmab buys ProfoundBio for US$ 1.8 bn; FDA okays Vanda’s Fanapt to treat bipolar disorder

April kicked off with Danish drugmaker Genmab buying ProfoundBio for US$ 1.8 billion in cash. ProfoundBio is a clinical stage b...

Impressions : 753

Novo buys Cardior Pharma for up to US$ 1.1 bn; FDA okays two meds for pulmonary arterial hypertension

This week’s Phispers has news on drug approvals, particularly meds to treat pulmonary arterial hypertension (PAH), Duchen...

Impressions : 1174

Madrigal’s Rezdiffra becomes first FDA-approved drug to treat NASH; Astra buys Fusion for US$ 2.4 bn

It was a week of drug approvals, as the US Food and Drug Administration (FDA) okayed several therapies before the close of the...

Impressions : 1495

FDA approves Wegovy to reduce cardiovascular risks; delays action on Lilly’s Alzheimer’s drug

In this week’s news, Novo Nordisk’s Wegovy became the first obesity drug cleared by the US Food and Drug Administra...

Impressions : 2025

Court dismisses Astra’s lawsuit over IRA price talks; Ozempic shows benefits to kidney, heart in diabetics with CKD

This week’s Phispers brings updates on the Inflation Regulation Act (IRA) in the US. A federal district court judge rejec...

Impressions : 860

India to have BMS’ largest R&D facility after US; its drug plants to face increased FDA inspections

This week’s Phispers has a lot of news from India. First, Bristol Myers Squibb (BMS) inaugurated a US$ 100 million facili...

Impressions : 1407

FDA okays Iovance’s cell therapy for skin cancer, issues warning letter to China’s Sichuan Deebio

The United States Food and Drug Administration (FDA) has granted accelerated approval to Iovance’s cell therapy — A...

Impressions : 988

Gilead acquires CymaBay for US$ 4.3 billion; Exscientia sacks founder CEO Andrew Hopkins

In this week’s Phispers, Gilead boosted its liver portfolio with the US$ 4.3 billion acquisition of CymaBay Therapeutics....

Impressions : 1405

Novo’s parent buys Catalent for US$ 16.5 bn, Lilly calls for scrutiny; Novartis acquires MorphoSys

The Novo Nordisk-Eli Lilly rivalry over obesity drugs got intensified with Novo Nordisk’s parent company acquiring contra...

Impressions : 895

Vertex’s non-opioid painkiller succeeds in late-stage trials, FDA finalizes CAR-T guidance

In Phispers this week, there is news of an experimental non-opioid painkiller from Vertex Pharmaceuticals showing positive res...

Impressions : 922

Six CAR-T therapies to carry boxed warning for secondary cancer; Sanofi buys Inhibrx for about US$ 2.2 billion

The US Food and Drug Administration (FDA) has mandated “black box” warnings on six major CAR-T cancer therapies ove...

Impressions : 2303

Lilly to launch Zepbound in more markets this year; Casgevy bags second FDA nod

This week’s Phispers brings you news from the annual World Economic Forum in Davos (Switzerland) where some senior execut...

Impressions : 1041

FDA allows Florida to import drugs from Canada; India mandates new GMP standards for drugmakers

In this week’s Phispers, the United States Food and Drug Administration (FDA) has allowed the state of Florida to import ...

Impressions : 1207

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass